Telaprevir Activity is unaffected by the Q80K Polymorphism in Hepatitis C virus Genotype 1a

Telaprevir Activity is unaffected by the Q80K Polymorphism in Hepatitis C virus Genotype 1a

Saved in:

Bibliographic Details
Main Author:	Stephen Shafran
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Canadian Journal of Gastroenterology and Hepatology
Online Access:	http://dx.doi.org/10.1155/2014/604942
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
by: T. Berg, et al.
Published: (2019-01-01)

Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
by: Jona T. Stahmeyer, et al.
Published: (2013-12-01)

Telaprevir in treatment of chronic hepatitis C: safety issues
by: T. M. Ignatova
Published: (2012-07-01)

The Hepatitis C Genotype 1 Paradox: Cost per Treatment Is Increasing, but Cost per Cure Is Decreasing
by: Stephen D Shafran
Published: (2015-01-01)

Treatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients
by: Conar R O’Neil, et al.
Published: (2015-01-01)

Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)

Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study
by: D. T. Abrurakhmanov, et al.
Published: (2014-07-01)

Response to: Comment on “Hepatitis C and the Sex Trade”
by: Stephen D. Shafran
Published: (2016-01-01)

Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
by: Raymond Odhiambo, et al.
Published: (2013-06-01)

Telaprevir: options of application in separate patient groups
by: M. V. Mayevskaya, et al.
Published: (2013-10-01)

Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis
by: Yinan Yao, et al.
Published: (2017-01-01)

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt
by: Ahmed A. Ali, et al.
Published: (2025-01-01)

Distribution of Hepatitis C Virus Genotypes in Canada: Results from the LCDC Sentinel Health Unit Surveillance System
by: RK Chaudhary, et al.
Published: (1999-01-01)

Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination
by: Apichat Kaewdech, et al.
Published: (2024-12-01)

Acute Coinfection with Hepatitis B and Hepatitis C Viruses
by: Brian M Yan, et al.
Published: (2005-01-01)

Hepatitis B Virus (HBV) Genotypes in an Ecuadorian Population: A Preliminary Study
by: Miguel Moncayo, et al.
Published: (2024-01-01)

Model for hepatitis C virus transmissions
by: Elamin H. Elbasha
Published: (2013-05-01)

Comment on “Emergence of Hepatitis B Virus Genotype F in Aligarh Region of North India”
by: Sibnarayan Datta
Published: (2014-01-01)

Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection
by: Yong-yu Mei, et al.
Published: (2020-01-01)

SMC translocation is unaffected by an excess of nucleoid associated proteins in vivo
by: Zhongqing Ren, et al.
Published: (2025-01-01)

Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance
by: Francesco Negro
Published: (2009-01-01)

Hepatitis C Virus Infection and Mixed Cryoglobulinemia
by: Gianfranco Lauletta, et al.
Published: (2012-01-01)

Morphologic Features of Extrahepatic Manifestations of Hepatitis C Virus Infection
by: Huaibin M. Ko, et al.
Published: (2012-01-01)

Seroprevalences of Hepatitis B Virus and Hepatitis C Virus among Participants of an Asian Health Fair in the Lower Mainland, British Columbia
by: Stephen Ip, et al.
Published: (2015-01-01)

Single-Dose Infliximab in Hepatitis C Genotype 1 Treatmentnaive Patients with High Serum Levels of Tumour Necrosis Factor-Alpha Does Not Influence the Efficacy of Pegylated Interferon Alpha-2B/Ribavirin Therapy
by: Curtis Cooper, et al.
Published: (2014-01-01)

Association between Interferon-Inducible Protein 6 () Polymorphisms and Hepatitis B Virus Clearance
by: Geun-Hee Park, et al.
Published: (2013-03-01)

CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian Guidelines for the Treatment of Hepatitis C Infection in HIV-hepatitis C Coinfected Adults
by: Mark Hull, et al.
Published: (2014-01-01)

Diagnosis and management of rheumatic manifestations of Hepatitis B, Hepatitis C and immunodeficiency Virus
by: Arun Ramesh Chogle
Published: (2017-01-01)

Hepatitis C Virus Adaptation to T-Cell Immune Pressure
by: A. Plauzolles, et al.
Published: (2013-01-01)

Hepatitis C Virus, Cryoglobulinemia, and Kidney: Novel Evidence
by: Fabrizio Fabrizi
Published: (2012-01-01)

In Vitro Systems for the Study of Hepatitis C Virus Infection
by: Garrick K. Wilson, et al.
Published: (2012-01-01)

Antibody to Hepatitis C Virus in Risk Groups in Canada
by: RK Chaudhary, et al.
Published: (1992-01-01)

Genotype Distribution of CNDP1 Polymorphisms in the Healthy Chinese Han Population: Association with HbA1c and Fasting Blood Glucose
by: Shiqi Zhang, et al.
Published: (2020-01-01)

Motor modules are largely unaffected by pathological walking biomechanics: a simulation study
by: Mohammad Rahimi Goloujeh, et al.
Published: (2025-01-01)

The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet—Remaining Challenges in Hepatitis C
by: Nicholas van Buuren, et al.
Published: (2016-01-01)

Hepatitis C Virus Evasion from RIG-I-Dependent Hepatic Innate Immunity
by: Helene Minyi Liu, et al.
Published: (2010-01-01)

Prevalence of Antibody to Hepatitis C Virus in Saudi Blood Donors
by: Bandar Al-Knawy, et al.
Published: (1995-01-01)

Recent Advances in Laboratory Diagnosis of Hepatitis C Virus Infection
by: RK Chaudhary
Published: (1994-01-01)

Characteristics of Hepatitis C Virus Infection in HIV-Infected People
by: Curtis L Cooper, et al.
Published: (2001-01-01)

Elevated Concentration of Defensins in Hepatitis C Virus-Infected Patients
by: Ehab H. Mattar, et al.
Published: (2016-01-01)